Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
NCT ID: NCT00524641
Last Updated: 2009-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1254 participants
OBSERVATIONAL
2007-07-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia
NCT00939341
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800
Local Phase 4 Pan-European SMART Study
NCT00463866
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
NCT00255255
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have already been on Symbicort SMART treatment
* Willing to give written informed consents to participate in the program.
Exclusion Criteria
* Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dinh Ngoc SY, MD
Role: STUDY_CHAIR
TB and Lung Disease Hospital, Hanoi
Tran Van Ngoc, MD, PhD
Role: STUDY_CHAIR
Cho Ray Hospital
Nguyen Hong Duc
Role: STUDY_CHAIR
Pharm Ngoc Thach Hospital
Do Van Dung, MD, PhD
Role: STUDY_CHAIR
Ho Chi Minh City Univ of Medicine and Pharmacist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Hanoi, , Vietnam
Research Site
Ho Chi Minh City, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-R84-AST-2007/3
Identifier Type: -
Identifier Source: secondary_id
NIS-RVN-SYM-2007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.